
Melanotan I
10 mg
Alpha-MSH analog with MC1R selectivity used in melanocortin receptor and pigmentation research.
Free U.S. shipping $175+

PT-141 (bremelanotide) is a cyclic melanocortin peptide derived from the Melanotan II scaffold, modified to shift its receptor preference toward MC4R.
Because MC4R is expressed predominantly in the central nervous system and is studied in relation to appetite and behavior pathways, this compound is used in preclinical research examining central melanocortin signaling rather than peripheral pigmentation.
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Analytical values reflect per-lot documentation and appear once a batch is released.
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
PT-141 emerged from the Melanotan II series with modifications that shifted its receptor-selectivity profile away from MC1R-dominant activity.
It has since been used as a comparison peptide in melanocortin-selectivity research.

10 mg
Alpha-MSH analog with MC1R selectivity used in melanocortin receptor and pigmentation research.

10 mg
Cyclic non-selective melanocortin agonist used in receptor pharmacology and comparative research.

10 mg
Nine-residue neurohypophysial peptide studied for oxytocin receptor signaling and social-behavior models.